Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.
about
Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies.Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's diseaseCholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story.Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance.Non-hydrolytic functions of acetylcholinesterase. The significance of C-terminal peptides.Characterization of antibodies that selectively detect alpha-synuclein in pathological inclusions.Regulation of dopamine D₃ receptor in the striatal regions and substantia nigra in diffuse Lewy body disease.Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.Agitation and psychosis associated with dementia with lewy bodies exacerbated by modafinil use.Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors?Cerebrospinal Fluid Aβ42 Levels: When Physiological Become Pathological State.Review: Sporadic Parkinson's disease: development and distribution of α-synuclein pathology.Synucleinopathies: common features and hippocampal manifestations.Abnormal Echogenicity of the Substantia Nigra, Raphe Nuclei, and Third-Ventricle Width as Markers of Cognitive Impairment in Parkinsonian Disorders: A Cross-Sectional Study.Gastrointestinal Transit Time in Parkinson's Disease Using a Magnetic Tracking System.Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias.Neurocognitive Deficits Distinguishing Mild Dementia with Lewy Bodies from Mild Alzheimer's Disease are Associated with Parkinsonism.Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study.Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subject.
P2860
Q35863410-5DFAEB07-685B-425B-90D7-ED133F5486C1Q35863422-B9199F63-F053-4B5A-A7CE-2AD15E800670Q36226675-42B7B57B-9DA1-4442-8176-7DAAB0C88922Q36475090-C02461D6-E9FD-4559-B268-7CC06E51297BQ36501660-9E0CE90B-D297-49DF-B021-D03B4D690F22Q37060542-08F68DD5-8998-445F-A79B-15153EF4D370Q37148311-034B9DF2-5122-44AB-A6C9-6D27D673FC53Q37228453-D92878E6-EC35-499E-A7D6-D19598D1A9D6Q37376010-4CF99BA9-0FB7-4F23-9876-DA4459D537B7Q37734694-B6F4407C-B4B4-454C-948E-E3D9D5BB8C62Q38132755-CC931BA5-5F60-4E55-8341-CB660CD06FC9Q38629788-E81F1E52-AB5C-440A-BE05-3526ACA77967Q38667942-76E9C0D3-6E3B-4526-BF17-2ED0F5CF613CQ39003423-11D560C9-B123-4F3D-973C-1203AAC6AD72Q42544369-266780C5-4757-4E96-AF6D-887C6A41CA42Q48540597-27AB14E8-5B18-406D-914C-4B5D576D6A6BQ48616026-3A2F6BA5-9DC0-44D0-9261-1AE6429B97C5Q50199884-E2CE6693-FDBF-43A7-8A52-C5CDDBC135C4Q50980479-96D1DADC-F778-4D59-999E-69DE71BE2BC6Q52568016-FF8439CC-7A18-49B9-BD38-B8F94EF436B7
P2860
Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.
@ast
Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.
@en
type
label
Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.
@ast
Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.
@en
prefLabel
Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.
@ast
Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.
@en
P356
P1476
Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.
@en
P2093
John E Duda
P356
10.1159/000074677
P478
17 Suppl 1
P577
2004-01-01T00:00:00Z